TrialEuropean journal of clinical pharmacology2018

Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants.

Charlotte H Maden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.